Skip to main content
SpringerLink
Log in

Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Møller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-3953-z.

  2. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–60.

    Article  PubMed  CAS  Google Scholar 

  3. JCGM. Evaluation of measurement data — Guide to the expression of uncertainty in measurement. 2008. www.bipm.org, September 2008.

  4. Barrington SF, Sulkin T, Forbes A, PWM J. All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting. Eur J Nucl Med Mol Imaging. 2018;45:316–7.

    Article  PubMed  Google Scholar 

  5. Laffon E, Marthan R. On the cutoff of baseline total metabolic tumor volume in high-tumor-burden follicular lymphoma. J Clin Oncol. 2017;35:919–20.

    Article  PubMed  Google Scholar 

  6. Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, et al. Reply to H.J.A. Adams et al and E. Laffon et al. J Clin Oncol. 2017;35:920–3.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CHU de Bordeaux, F-33000, Bordeaux, France

    Eric Laffon & Roger Marthan

  2. Univ. Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, F-33000, Bordeaux, France

    Eric Laffon & Roger Marthan

  3. INSERM U-1045, Centre de Recherche Cardio-Thoracique de Bordeaux, F-33000, Bordeaux, France

    Eric Laffon & Roger Marthan

  4. Service de Médecine Nucléaire, Hôpital du Haut-Lévèque, Avenue de Magellan, 33604, Pessac, France

    Eric Laffon

Authors
  1. Eric Laffon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger Marthan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric Laffon.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

Not applicable.

Informed consent

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laffon, E., Marthan, R. Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?. Eur J Nucl Med Mol Imaging 45, 1832–1833 (2018). https://doi.org/10.1007/s00259-018-4049-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-018-4049-5

Search

Navigation